Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cabometyx
Cabometyx
Pfizer, Exelixis cancer drugs get FDA approval for wider use
Reuters
Wed, 12/20/17 - 09:39 am
Pfizer
Exelixis
Cabometyx
kidney cancer
Bosulif
blood cancer
Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale
Motley Fool
Thu, 09/14/17 - 06:56 pm
Exelixis
Bristol-Myers Squibb
kidney cancer
Cabometyx
Opdivo
Yervoy
2 Big Reasons Exelixis, Inc. Added $626 Million to Its Market Cap in August
Motley Fool
Sat, 09/9/17 - 09:28 am
Exelixis
earnings
Cabometyx
What's Pfizer's Excuse for Not Buying Exelixis?
Motley Fool
Wed, 11/30/16 - 09:46 pm
Pfizer
Exelixis
M&A
Cabometyx
kidney cancer
Sutent
3 Things Exelixis Must Do to Survive and Thrive in 2017
Motley Fool
Thu, 11/17/16 - 04:43 pm
Exelixis
cabozantinib
Cabometyx
Cometriq
5 Reasons Exelixis's Cabometyx Is Set To Be The Next Blockbuster Opportunity
Seeking Alpha
Thu, 11/10/16 - 10:59 am
Exelixis
Cabometyx
renal cell carcinoma
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Motley Fool
Mon, 10/17/16 - 11:49 am
Pfizer
Bristol-Myers Squibb
Exelixis
Cabometyx
kidney cancer
Sutent
Opdivo
These 3 Little Biotechs Just Scored Big
Motley Fool
Tue, 10/11/16 - 09:33 pm
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
Exelixis and Pfizer drugs compete in kidney cancer trial
Yahoo/Reuters
Mon, 10/10/16 - 09:15 am
kidney cancer
Exelixis
Pfizer
Sutent
Cabometyx
Exelixis, Inc. Gets Some ASCO Love
Motley Fool
Tue, 06/7/16 - 11:16 am
Exelixis
ASCO 2016
Cabometyx
renal cell carcinoma
Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX™ (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO
Yahoo
Sun, 06/5/16 - 11:59 am
Exelixix
Ipsen
clinical trials
advanced renal cell carcinoma
Cabometyx
ASCO 2016
Pages
« first
‹ previous
1
2
3